Novartis AG (SWX:NOVNEE)

Market Cap	191.75B
Revenue (ttm)	43.89B
Net Income (ttm)	10.86B
Shares Out	n/a
EPS (ttm)	5.45
PE Ratio	17.66
Forward PE	14.56
Dividend	n/a
Ex-Dividend Date	n/a

Volume	124,577
Average Volume	179,824
Open	99.09
Previous Close	98.37
Day's Range	98.14 - 99.13
52-Week Range	81.55 - 104.54
Beta	0.49
RSI	56.26
Earnings Date	Oct 28, 2025

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 75,883
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: NOVNEE

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD